期刊文献+

他汀类药物防治冠状动脉粥样硬化心脏病112例分析 被引量:13

Preventive Effect of Statin Drugs on 112 Cases of Patients with Heart of Coronary Atherosclerosis
暂未订购
导出
摘要 目的:探讨他汀类药物在冠心病二级防治中的作用。方法:回顾性分析112例冠心病患者经他汀类药物治疗前后的指标及效果。结果:他汀类药物治疗前后指标比较,差异有显著性意义(P<0.05或P<0.01)。结论:他汀类药物对冠心病患者有积极的防治作用。 Objective:In the secondary prevention of coronary heart disease,lipid-lowering drug treatment is more and more attention,more and more large-scale clinical trials confirm that statins significantly reduced the incidence of coronary heart disease and cardiovascular events,and strengthen Lipid-lowering therapy in a very high-risk patients becomes more and more attention.In this paper,112 cases of hospital outpatient secondary prevention of coronary heart disease in patients with lipid therapy in clinical Practice review to explore the statin drugs,clinical application
作者 万军
机构地区 舒城县人民医院
出处 《安徽卫生职业技术学院学报》 2010年第3期76-77,共2页 Journal of Anhui Health Vocational & Technical College
关键词 冠心病 他汀类药物 合理应用 Heart of coronary Atherosclerosis statin Drugs Reasonable application
  • 相关文献

参考文献5

二级参考文献43

  • 1李光伟,Step.,L.检测人群胰岛素敏感性的一项新指数[J].中华内科杂志,1993,32(10):656-660. 被引量:2126
  • 2孔晓东.药物经济学:概念、方法和应用[J].国外医学(药学分册),1994,21(1):13-18. 被引量:429
  • 3王安才,成蓓,谢晓竟,徐浩.阿托伐他汀对自发性高血压大鼠血压和心肌血管紧张素Ⅱ1型和2型受体表达的影响[J].中国动脉硬化杂志,2005,13(1):40-44. 被引量:19
  • 4Vaughan CJ, Gotto AM Jr, Basson CT. The evolving role of statins in the management of atherosclerosis[J]. J Am CollCardiol,2000, 35:1.
  • 5BrouetA, SonveauxP,DessyC, etla.lHsp90 and caveolin are key targets for the proangiogenic nitric oxide-mediated effects of statins[J]. Circ Res, 2001, 89(10): 866-873.
  • 6HattoriY,NakanishiN,AkimotoK, et al HMG-CoA reductase inhibitorincreasesGTPcyclohydrolase ImRNA and tetrahydrobiopterin in vascular endothelial cells[J]. ArteriosclerThrombVasc Biol,2003,23(2): 176 - 182.
  • 7YueTL,Gu JL,WangC, etla.l Extracellular signal-regulated kinase plays an essential role in hypertrophic agonists, endothelin-1 and phenylephrine-induced cardiomyocyte hypertrophy[J]. JBiolChem, 2000, 275(48): 37895-37901.
  • 8Kleemann R,Princen HM, Emeis J J, et al Rosuvastatin reduces atherosclerosis developrnentbeyond and independentof its plasma cholesterol-lowering effect in APOE^* 3-Leiden transgenicmice: evidence forantiinflammatory effects ofrosuvastatin[J]. Circulation, 2003, 108(11): 1368-1374.
  • 9Kaneyuki U,Ueda S, Yamagishi S, et al Pitavastatin inhibits lysophosphatidicacid-induced proliferation andmonocyte chemoattractantprotein-1 expression inaortic smoothmuscle cells by suppressingRac-1-mediated reactive oxygen species generation[J]. Vase Pharmacol,2007, 46(4): 286- 292.
  • 10Susie D,Varagie J,Ahn J, et al.Beneficialpleiotropic vascular effects of rosuvastatin in two hypertensivemodels[J]. JAm CollCardio,1 2003, 42(6): 1091 - 1097.

共引文献107

同被引文献98

引证文献13

二级引证文献98

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部